|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.220 USD | -6.33% |
|
-4.72% | +36.20% |
| 07-08 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 07-08 | Ovid Therapeutics Inc. Announces Executive Changes, Effective July 6, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OVID THERAPEUTICS INC. | Bio Therapeutic Drugs | -6.33% | -4.72% | +36.20% | +344.00% | -40.48% | 414M |  |  | |
- Stock Market
- Stocks
- OVID Stock
- Charts Ovid Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
